INTRECATE Trademark

Trademark Overview


On Friday, October 22, 2021, a trademark application was filed for INTRECATE with the United States Patent and Trademark Office. The USPTO has given the INTRECATE trademark a serial number of 97087466. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, May 14, 2025. This trademark is owned by Intrecate Biotherapeutics, Inc.. The INTRECATE trademark is filed in the Pharmaceutical Products category with the following description:

House mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies; pharmaceutical preparations for human use, namely, diagnostic preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
intrecate

General Information


Serial Number97087466
Word MarkINTRECATE
Filing DateFriday, October 22, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, May 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 21, 2023

Trademark Statements


Goods and ServicesHouse mark for a full line of pharmaceutical preparations for human use; pharmaceutical preparations for human use for treatment and prevention of inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions; pharmaceutical preparations for human use for treatment and prevention of pain; pharmaceutical preparations for human use for treatment and prevention of allergies; pharmaceutical preparations for human use, namely, diagnostic preparations for medical purposes; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals
Pseudo MarkINTRICATE

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntrecate Biotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 022102600

Party NameIntrecate Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 022102600

Trademark Events


Event DateEvent Description
Monday, August 1, 2022ASSIGNED TO EXAMINER
Tuesday, October 26, 2021NEW APPLICATION ENTERED
Monday, November 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 2, 2022NON-FINAL ACTION WRITTEN
Tuesday, August 2, 2022NON-FINAL ACTION E-MAILED
Tuesday, August 2, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 2, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 2, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 2, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 1, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 21, 2023PUBLISHED FOR OPPOSITION
Tuesday, March 21, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 16, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, August 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 18, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, November 6, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 6, 2023SOU EXTENSION 1 FILED
Monday, April 22, 2024SOU EXTENSION 2 GRANTED
Monday, November 6, 2023SOU EXTENSION 1 GRANTED
Wednesday, November 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 22, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 22, 2024SOU EXTENSION 2 FILED
Tuesday, April 23, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 3, 2024SOU EXTENSION 3 FILED
Wednesday, May 14, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, May 14, 2025SOU EXTENSION 4 FILED
Wednesday, May 14, 2025SOU EXTENSION 4 GRANTED
Wednesday, May 14, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2024SOU EXTENSION 3 GRANTED
Tuesday, September 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED